Chandresh Harjivan, BPharm, MPH, MBA
Advertisement
Articles by Chandresh Harjivan, BPharm, MPH, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia
2
FDA Approves IV, Subcutaneous Atezolizumab for dMMR Colon Cancer
3
MASH Fibrosis, Not Resolution, Predicts Mortality: Zobair Younossi, MD
4
Timing COVID-19 Protection With VYD2311: Michael Mina, MD, PhD
5